Table 1

Assessment instruments proposed for the current study




12-, 18-, 24-, 30- 36-months

Tobacco Use

Opiate Treatment Index (OTI, quantity/frequency) [14]

Point Prevalence and Continuous Abstinence

Readiness to Quit Smoking [15]



Fagerstrom Test for Nicotine Dependence [16]

Expired Carbon Monoxide

Minnesota Nicotine Withdrawal Scale (MNWS-R)[17]

Physical Activity

Readiness to change physical activity [18]



Physical activity screen (past week)

Average minutes walking per week

International Physical Activity Questionnaire [19]

Dietary Habits

Readiness to change eating habits



24-hour recall of eating patterns

Other CVD Risk Factors

OTI- alcohol and cannabis

Beck Depression Inventory - II [20]

Brief Symptom Inventory [21]

Body mass index (height, weight)

Waist-hip ratio (cms)

Auscultatory Blood pressure

Fingerprick Blood Tests (glucose, cholesterol, lipids)

Treatment and Service Utilisation [22]

Diagnosis of psychosis and Symptom Measure

Brief Psychiatric Rating Scale [23]

Mini International Neuropsychiatric Interview [22]




Global Assessment of Functioning [24]

Medical Outcome Survey SF-36 [25]

Quality of Life Scale [26]

Impact of Weight on Quality of Life Questionnaire [27]

Therapeutic Alliance & Intervention Satisfaction [28]



Baker et al. BMC Public Health 2011 11:10   doi:10.1186/1471-2458-11-10

Open Data